{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Genenta Science S.p.A."},"Symbol":{"label":"Symbol","value":"GNTA"},"Address":{"label":"Address","value":"VIA OLGETTINA NO. 58, MILAN, 20132, Italy"},"Phone":{"label":"Phone","value":"+39 22643468120"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"Europe"},"CompanyDescription":{"label":"Company Description","value":"Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's product under development includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy."},"CompanyUrl":{"label":"Company Url","value":"https://www.genenta.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Carlo Russo","title":"Chief Medical Officer & Head-Development"},{"name":"Pierluigi Paracchi","title":"Chairman & Chief Executive Office"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}